Table: OncoTherapy Science -Q1 group results

OncoTherapy Science

09/08/2024 09:00

Aug 9 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            100 mln             148 mln                    
                 (-32.0 pct)         (-61.6 pct)                  
  Operating     loss 290 mln        loss 386 mln                  
  Recurring     loss 302 mln        loss 397 mln                  
  Net           loss 302 mln        loss 400 mln                  
  EPS           loss 1.30 yen       loss 1.99 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T